Aurefluidics

Aurefluidics is a high-tech biotechnology company specializing in the development of intelligent MEMS microfluidic chips and 'liquid digitization' technology. The company leverages an 8-inch MEMS production line to design and manufacture CMOS-MEMS inkjet printing chips, which are applied in high-throughput single-cell sorting, organoid engineering, and nanomedicine formulation. Their platform aims to bridge the gap between laboratory-scale discovery and commercial-scale manufacturing for advanced therapies. Founded in 2018 as a spin-off from the Shanghai Industrial Microtechnology Research Institute (SITRI), the company has established itself as a leader in the Chinese microfluidics market. Its product portfolio includes automated single-cell processing systems, organoid biofabricators, and perfusion systems for organ-on-a-chip models, serving sectors such as drug R&D, clinical diagnostics, and cell/gene therapy.